In my 20+ years of leading digital transformation programs across life sciences and MedTech, I’ve had a front-row seat to the constant tug-of-war between innovation and compliance. On one hand, the ...
Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate regulatory delays for blockbuster ophthalmology drug Eylea HD due to ...
Toyota's largest manufacturing plant in Georgetown, Kentucky, is investing over $1.8 billion in new technology. A new system called K-flex allows the plant to build SUVs, hybrids, EVs and sedans on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results